home / stock / kaltf / kaltf quote
Last: | $0.11 |
---|---|
Change Percent: | -7.48% |
Open: | $0.11889 |
Close: | $0.11 |
High: | $0.1189 |
Low: | $0.11 |
Volume: | 1,720 |
Last Trade Date Time: | 03/15/2022 04:53:25 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.11 | $0.11889 | $0.11 | $0.1189 | $0.11 | 1,720 | 03-15-2022 |
$0.11 | $0.11 | $0.11 | $0.11 | $0.11 | 500 | 03-11-2022 |
$0.1268 | $0.119154 | $0.1268 | $0.1268 | $0.1192 | 6,632 | 03-10-2022 |
$0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 8,244 | 03-08-2022 |
$0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 20,898 | 03-07-2022 |
$0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 454 | 03-04-2022 |
$0.1224 | $0.1225 | $0.1224 | $0.1225 | $0.1224 | 2,215 | 03-03-2022 |
$0.19 | $0.19 | $0.19 | $0.19 | $0.19 | 100 | 03-02-2022 |
$0.12 | $0.1376 | $0.12 | $0.1599 | $0.12 | 88,588 | 03-01-2022 |
$0.123 | $0.123 | $0.123 | $0.123 | $0.123 | 205 | 02-28-2022 |
$0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 14,511 | 02-25-2022 |
$0.1247 | $0.1298 | $0.1247 | $0.1298 | $0.1247 | 6,463 | 02-24-2022 |
$0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 208 | 02-23-2022 |
$0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 2,650 | 02-22-2022 |
$0.122 | $0.12375 | $0.122 | $0.1247 | $0.122 | 27,500 | 02-21-2022 |
$0.122 | $0.12375 | $0.122 | $0.1247 | $0.122 | 27,500 | 02-18-2022 |
$0.1214 | $0.1229 | $0.1214 | $0.1229 | $0.1214 | 5,260 | 02-17-2022 |
$0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 504 | 02-16-2022 |
$0.1293 | $0.13935 | $0.1293 | $0.1394 | $0.1293 | 5,400 | 02-15-2022 |
$0.1389 | $0.1389 | $0.1389 | $0.1389 | $0.1372 | 48,505 | 02-14-2022 |
News, Short Squeeze, Breakout and More Instantly...
Kalytera Therapeutics Company Name:
KALTF Stock Symbol:
OTCMKTS Market:
Kalytera Therapeutics Website:
SAN FRANCISCO, CA and TORONTO, ON , Feb. 22, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the " Company " or " Claritas ") today announced that it has received comments from the Australian Human Research Ethics Committee (the “...
SAN FRANCISCO, CA and TORONTO, ON, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the " Company " or " Claritas ") today announced that the Australian Human Research Ethics Committee (HREC) will meet on February 16 th to...
SAN FRANCISCO, CA and TORONTO, ON, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the “ Company ” or “ Claritas ”) today announced revised, improved pricing for the initial tranche of funds that the Co...